| Diana M Guerra, MD | |
|
16651 Southwest Fwy, Suite 450, Sugar Land, TX 77479-2345 | |
| (281) 276-0827 | |
| (281) 275-0760 |
| Full Name | Diana M Guerra |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 29 Years |
| Location | 16651 Southwest Fwy, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023200623 | NPI | - | NPPES |
| 299091308 | Medicaid | TX | |
| 8FT835 | Other | TX | BLUE CROSS BLUE SHIELD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
The American Association of Colleges of Pharmacy (AACP) will honor Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, for her excellence as a teacher, her outstanding achievements as a researcher and scholar, and her overall impact on pharmacy education and the profession.
Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.
In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.
› Verified 2 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
The American Association of Colleges of Pharmacy (AACP) will honor Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, for her excellence as a teacher, her outstanding achievements as a researcher and scholar, and her overall impact on pharmacy education and the profession.
Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.
In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.
› Verified 2 days ago
| Entity Name | Baylor St Lukes Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740485879 PECOS PAC ID: 9133213192 Enrollment ID: O20070920000863 |
News Archive
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
The American Association of Colleges of Pharmacy (AACP) will honor Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, for her excellence as a teacher, her outstanding achievements as a researcher and scholar, and her overall impact on pharmacy education and the profession.
Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.
In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.
› Verified 2 days ago
| Entity Name | Tmh Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
The American Association of Colleges of Pharmacy (AACP) will honor Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, for her excellence as a teacher, her outstanding achievements as a researcher and scholar, and her overall impact on pharmacy education and the profession.
Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.
In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.
› Verified 2 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
The American Association of Colleges of Pharmacy (AACP) will honor Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, for her excellence as a teacher, her outstanding achievements as a researcher and scholar, and her overall impact on pharmacy education and the profession.
Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.
In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana M Guerra, MD 16651 Southwest Fwy, Suite 450, Sugar Land, TX 77479-2345 Ph: (281) 276-0827 | Diana M Guerra, MD 16651 Southwest Fwy, Suite 450, Sugar Land, TX 77479-2345 Ph: (281) 276-0827 |
News Archive
ViPS, a General Dynamics Information Technology company, today announces its next-generation STARS Solutions suite, an advanced, comprehensive solution to assist health payers - organizations liable for healthcare coverage for plan members or beneficiaries - stop healthcare fraud, waste and abuse (FWA).
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine plus placebo in relapsed-refractory adult acute myeloid leukemia (AML).
The American Association of Colleges of Pharmacy (AACP) will honor Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, for her excellence as a teacher, her outstanding achievements as a researcher and scholar, and her overall impact on pharmacy education and the profession.
Currently, the world generic drug market is approaching $40 billion. Over the next five years, the market is expected to grow 10-15% annually.
In a study that was presented at the Society for Maternal-Fetal Medicine's annual meeting in San Francisco, Biocell Center, the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking.
› Verified 2 days ago
Vandana Khera, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 18717 University Blvd Bldg 2, Suite 105, Sugar Land, TX 77479 Phone: 281-208-3322 Fax: 281-208-3393 | |
Susan Vijayan Mathew, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Fl 3, Sugar Land, TX 77479 Phone: 281-275-0897 | |
Saif K Altaie, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-274-7000 | |
Priya N. Oolut, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16659 Southwest Fwy Ste 421, Sugar Land, TX 77479 Phone: 281-325-0005 Fax: 713-512-2247 | |
Dr. Htut Kyaw Win, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy Ste 360, Sugar Land, TX 77479 Phone: 713-790-0841 Fax: 713-790-9963 | |
Cathlyn Anderson, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 15200 S Us 59 Highway Suite 360, Sugar Land, TX 75075 Phone: 832-237-3500 Fax: 832-237-0200 | |
Angela Denise Mcgee, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 11555 University Blvd, Sugar Land, TX 77478 Phone: 713-442-9100 |